NY Times Does it Again – Drug Advertisers Get Front Page Coverage to Boost SSRI Market

NY Times Does it Again – Drug Advertisers Get Front Page Coverage to Boost SSRI Market Wed, 2 Jun 2004 The New York Times saw fit to print a report about preliminary, unpublished findings of a study whose authors claim to have “found that Prozac helps teenagers overcome depression far…

"Drug Companies Should Make Their Studies Public" NYT

“Drug Companies Should Make Their Studies Public” NYT Wed, 13 Aug 2003 Concealed and inaccessible research findings are undermining the integrity of medicine, the advancement of scientific knowledge, and most importantly, secrecy is putting people’s lives in jeopardy because prescribing doctors are ignorant about adverse – even lethal – drug…

Dr. Arif Kahn analysis of Psych Drug Trials Reveals High Suicide risk

September 6, 2002. Dr. Arif Kahn analysis of Psych Drug Trials Reveals High Suicide risk. FYI Clinical Psychiatry News online reports (below) that an independent analysis of the suicide rate in psychotropic drug trials– for drugs approved by the FDA between 1985-2000– found that the NEW DRUGS did NOT REDUCE…

AMA Serves Pharma Marketing Priority/ FDA To Add Warnings on ADHD drugs–Concerta, Ritalin, Strattera, Adderall

AMA Serves Pharma Marketing Priority/ FDA To Add Warnings on ADHD drugs–Concerta, Ritalin, Strattera, Adderall Wed, 29 Jun 2005 The FDA is finally taking note of the fact that many drugs prescribed for the treatment of psychiatric problems are CAUSING serious psychiatric and cardiovascular problems in children and adolescents !…

Recycled drugs: failed antidepressants– Stratera marketed for ADHD; Cymbalta for incontinence

Recycled drugs: failed antidepressants– Stratera marketed for ADHD; Cymbalta for incontinence Mon, 26 Apr 2004 A front page article in The Wall Street Journal (excerpt below) provides a roadmap of failed Eli Lilly drugs which the company repackaged for a different condition than the one for which the drugs had…

British Psychiatrists Debate: "Clinical trials of antidepressant medications are producing meaningless results"

British Psychiatrists Debate: “Clinical trials of antidepressant medications are producing meaningless results” Wed, 27 Aug 2003 “The fact that most people support the psychopharmacological orthodoxy is, in itself, no argument and it is important to examine the evidence before drawing conclusions.” The psychiatric establishment is on trial–its foundation and claimed…

FDA Advisory Suicide Risk for Adults on Antidepressants / Advisory Committee Resistant to issue Warnings on ADHD drugs

FDA Advisory Suicide Risk for Adults on Antidepressants / Advisory Committee Resistant to issue Warnings on ADHD drugs Fri, 1 Jul 2005 Under public and congressional pressure to disclose fully the hazardous effects of widely prescribed drugs, the FDA is beginning to acknowledge the long-denied evidence: psychotropic drugs may INDUCE…

Are SSRIs and Atypical Antidepressants Safe/ Effective for Children/ Adolescents/ Neonates?

Are SSRIs and Atypical Antidepressants Safe / Effective for Children / Adolescents/ Neonates? Wed, 2 Mar 2005 The American psychiatric establishment continues to operate within a “head in the sand” culture of denial when confronted with compelling evidence that has been scientifically replicated showing that their prescribing of antidepressants for…

GlaxoSmithKline CEO: "We had to absorb a number of hits"

GlaxoSmithKline CEO: “We had to absorb a number of hits” Mon, 16 Feb 2004 Antidepressant drug safety issues are beginning to have a financial impact. Dow Jones reports: “GlaxoSmithKline PLC said its net income fell 6% in the fourth quarter, hurt by previously announced legal costs related to its anti-inflammatory…

FDA Alert: Effexor warnings added for neonatal adverse effects and suicidality risk

FDA Alert: Effexor warnings added for neonatal adverse effects and suicidality risk Tue, 29 Jun 2004 On June 28, the FDA and Wyeth issued a new MedWatch drug Alert to healthcare professionals: “Neonates exposed to Effexor, other SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors), or SSRIs (Selective Serotonin Reuptake Inhibitors), late…

Can a Popular Antidepressant Cause Teenage Suicide? Boston Globe

Can a Popular Antidepressant Cause Teenage Suicide? Boston Globe Wed, 6 Aug 2003 For years, drug manufacturers and regulators (in the UK and US) have falsely maintained that antidepressants–such as Paxil (Seroxat), Prozac, and the other SSRIs–reduce the risk of suicide, and, they maintained, the drugs are not addictive. An…